9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death

      Read this article at

      ScienceOpenPublisher
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: not found
          • Article: not found

          Nitric oxide synthases in mammals.

            • Record: found
            • Abstract: not found
            • Article: not found

            Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

              • Record: found
              • Abstract: found
              • Article: not found

              Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.

              Mice deficient in inducible nitric oxide synthase (iNOS) were generated to test the idea that iNOS defends the host against infectious agents and tumor cells at the risk of contributing to tissue damage and shock. iNOS-/-mice failed to restrain the replication of Listeria monocytogenes in vivo or lymphoma cells in vitro. Bacterial endotoxic lipopolysaccharide (LPS) caused shock and death in anesthetized wild-type mice, but in iNOS-/-mice, the fall in central arterial blood pressure was markedly attenuated and early death averted. However, unanesthetized iNOS-/-mice suffered as much LPS-induced liver damage as wild type, and when primed with Propionobacterium acnes and challenged with LPS, they succumbed at the same rate as wild type. Thus, there exist both iNOS-dependent and iNOS-independent routes to LPS-induced hypotension and death.

                Author and article information

                Journal
                Journal of Clinical Investigation
                J. Clin. Invest.
                American Society for Clinical Investigation
                0021-9738
                March 15 2002
                March 15 2002
                : 109
                : 6
                : 735-743
                Article
                10.1172/JCI200213265
                b21334d7-a8b1-49c2-820f-7f6e6422c0e2
                © 2002
                History

                Comments

                Comment on this article

                Related Documents Log